Section 1. XVI Symposium «Current problems of chemistry, biology and technology of natural compounds»

THE EFFECT OF MKС COMPOSITION ON COAGULATION HEMOSTASIS PARAMETERS IN EXPERIMENTAL PULMONARY THROMBOSIS

N.B. Nurbekova 🎤
Institute of Bioorganic Chemistry, Academy of Sciences of the Republic of Uzbekistan, Uzbekistan
N.L. Vypova
Institute of Bioorganic Chemistry, Academy of Sciences of the Republic of Uzbekistan, Uzbekistan
N.A. Tagayalieva
Institute of Bioorganic Chemistry, Academy of Sciences of the Republic of Uzbekistan, Uzbekistan
R.A. Yakubova
Institute of Bioorganic Chemistry, Academy of Sciences of the Republic of Uzbekistan, Uzbekistan
L.U. Makhmudov
Institute of Bioorganic Chemistry, Academy of Sciences of the Republic of Uzbekistan, Uzbekistan
👁️ 1 Views
📥 0 Downloads

Abstract

A hypercoagulable state is accompanied by changes in coagulogram parameters, increased fibrinogen concentration, and impaired fibrin clot formation. The search for new drugs capable of effectively normalizing plasma hemostasis parameters remains a priority area of research. To evaluate the effect of the MKС formulation on coagulation hemostasis parameters. The study was conducted on 25 white outbred mice, weighing 25±2 g, with 5 animals per group. To induce a model of pulmonary thrombosis, animals in the control and experimental groups were injected with a mixture of collagen (0.5 mg/kg) and adrenaline (0.06 mg/kg) solutions, into the caudal vein. MKС was administered orally as a single dose 2 hours prior to the administration of the thrombotic agent at doses of 0.5 and 1.0 mg/kg, whilst Evalar Dihydroquercetin was administered at a dose of 100 mg/kg. Twenty-four hours after the administration of the thrombotic agents, the following coagulation parameters were assessed: prothrombin time (PT), activated partial thromboplastin time (APTT), plasma recalcification (VRP), thrombin time (TT), and fibrinogen (F).

Share this Publication

𝕏 Sharein Share✈️ Share💬 Sharef Share

Publication Details

Published Date07/10/2026
ConferenceInternational Conference “Biologically active compounds: From chemistry to medicine”
DOI10.5281/zenodo.23061330
Pages196
CC BY 4.0

This article is licensed under a Creative Commons Attribution 4.0 International License.